688613 奥精医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.1920.975-0.9094.0407.476
总资产报酬率 ROA (%)0.1790.892-0.8263.6336.600
投入资产回报率 ROIC (%)0.1860.938-0.8713.8477.045

边际利润分析
销售毛利率 (%)63.28268.65971.07282.67583.376
营业利润率 (%)1.0655.363-3.57321.63339.264
息税前利润/营业总收入 (%)1.8976.409-4.52621.62637.708
净利润/营业总收入 (%)1.1304.247-8.31923.38737.382

收益指标分析
经营活动净收益/利润总额(%)-320.217-76.678213.95732.63381.250
价值变动净收益/利润总额(%)429.101107.254-200.47836.70010.629
营业外收支净额/利润总额(%)21.2082.35417.6300.204-0.119

偿债能力分析
流动比率 (X)44.83314.92522.89323.64123.574
速动比率 (X)41.96913.98621.84822.99723.196
资产负债率 (%)4.8307.4517.7448.0339.149
带息债务/全部投入资本 (%)0.7851.9502.1592.6582.234
股东权益/带息债务 (%)12,399.4394,932.6754,448.1433,593.5134,249.586
股东权益/负债合计 (%)1,955.2021,231.1601,176.9061,127.201975.982
利息保障倍数 (X)3.4856.99124.019-418.870-24.990

营运能力分析
应收账款周转天数 (天)67.68276.124110.45578.01048.965
存货周转天数 (天)360.684337.608263.597234.048164.822